Explicitly accounting for antiretroviral drug uptake in theoretical HIV models predicts long-term failure of protease-only therapy
From MaRDI portal
Publication:1788644
DOI10.1016/J.JTBI.2007.11.032zbMath1398.92152OpenAlexW2127225337WikidataQ51896911 ScholiaQ51896911MaRDI QIDQ1788644
Publication date: 8 October 2018
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2007.11.032
Related Items (7)
Can the viral reservoir of latently infected \(CD4^{+}\) T cells be eradicated with antiretroviral HIV drugs? ⋮ Mathematical modelling of enfuvirtide and protease inhibitors as combination therapy for HIV ⋮ Kinetic model of HIV infection including hematopoietic progenitor cells ⋮ A model for SARS-CoV-2 infection with treatment ⋮ Anti-viral drug treatment along with immune activator IL-2: a control-based mathematical approach for HIV infection ⋮ The effect of vaccination to dendritic cell and immune cell interaction in HIV disease progression ⋮ Viral dynamics of an HIV model with pulse antiretroviral therapy and adherence
Cites Work
- Unnamed Item
- HIV-1 infection and low steady state viral loads
- Distinct effects of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infection with impulsive drug effects
- Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity
- Mathematical analysis of delay differential equation models of HIV-1 infection
- A model of HIV-1 pathogenesis that includes an intracellular delay
- Costs versus benefits: best possible and best practical treatment regimens for HIV
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- Population HIV‐1 Dynamics In Vivo: Applicable Models and Inferential Tools for Virological Data from AIDS Clinical Trials
This page was built for publication: Explicitly accounting for antiretroviral drug uptake in theoretical HIV models predicts long-term failure of protease-only therapy
